Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?
Wataru YamagamiNobuyuki SusumuTakeshi MakabeKensuke SakaiHiroyuki NomuraFumio KataokaAkira HiraswaKouji BannoDaisuke AokiPublished in: Journal of gynecologic oncology (2018)
Repeated treatment is sufficiently effective for intrauterine recurrence after hormonal therapy for AEH/early G1.